LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.

Trial Details

NCT ID
NCT05939063
Phase
NA
Sponsor
Fudan University
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • LRAMPS
  • LDP
Locations (sample)
  • Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

  • Clinically diagnosed as resectable left-sided pancreatic cancer before surgery.
  • Imaging tumor diameter ≤ 4 cm.
  • Located ≥ 1cm from the celiac trunk.
  • Tumor didn't invade the fascial layer behind the pancreas.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →